Staar Surgical price target raised to $28 from $20 at Canaccord

Canaccord raised the firm’s price target on Staar Surgical (STAA) to $28 from $20 and keeps a Hold rating on the shares. The firm raised its target after Alcon (ALC) will purchase all outstanding shares of Staar for $28/share, giving them a $1.5B total enterprise value.